Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

IImmunovant, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
I

Immunovant, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
    Sep 23, 2026Immunovant, Inc. (IMVT) Press Releases
  • Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
    Aug 6, 2026Immunovant, Inc. (IMVT) Press Releases
  • Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
    Jul 23, 2026Immunovant, Inc. (IMVT) Press Releases
  • Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026
    May 20, 2026Immunovant, Inc. (IMVT) Press Releases
  • Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026
    May 11, 2026Immunovant, Inc. (IMVT) Press Releases
  • Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
    Apr 2, 2026Immunovant, Inc. (IMVT) Press Releases
  • Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
    Feb 6, 2026Immunovant, Inc. (IMVT) Press Releases
  • Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
    Jan 23, 2026Immunovant, Inc. (IMVT) Press Releases
  • Immunovant Announces Pricing of $550 Million Common Stock Financing
    Dec 11, 2025Immunovant, Inc. (IMVT) Press Releases
  • Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025
    Nov 10, 2025Immunovant, Inc. (IMVT) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions